news

« BACK

Pharmacology



Results 1 - 20 of 45.
1 2 3 Next »


Health - Pharmacology - 23.11.2022
Diabetes: do some sport!
Diabetes: do some sport!
Regular exercise may protect pancreatic beta cells from stresses that contribute to diabetes. Researchers from the ULB Center for Diabete Research observed this in a study published in Diabetologia . Diabetes is characterized by a progressive loss of pancreatic beta cells, the same cells that produce insulin and thus maintain the right level of sugar in the blood.

Pharmacology - Health - 03.05.2022
Antibiotics impact gut microbiome and antimicrobial resistance
Antibiotics impact gut microbiome and antimicrobial resistance
Antibiotics are commonly used to treat infections and ensure the safety of surgical procedures. However, their overuse has led to the emergence and spread of resistant bacteria, resulting in an -arms race- whereby ever more potent drugs are becoming a necessity.

Health - Pharmacology - 21.04.2022
The why behind mild COVID-19
All-Luxembourg study helps to anticipate a personal COVID-19 health trajectory From the start of the COVID-19 pandemic, the majority of published studies have focused on severe COVID-19 patients in order to understand the causes of critical illness. However, it is equally, if not more important to understand the protective immune factors in our body.

Health - Pharmacology - 12.04.2022
B or not to B: Insights in the regulation of anti-viral immunity
Researchers delve into the inner workings of the antibody immune response, finding key differences in the metabolism of two closely related immune cell subsets. Protection against viral diseases is a key role of our body's immune response, where antibodies are generated to seek out invading species and either neutralise or mark them for destruction.

Health - Pharmacology - 09.03.2022
VUB spin-off Lavima Fertility develops novel fertility treatment that reduces risks and burden
Couples unable to get pregnant naturally often resort to In Vitro Fertilisation (IVF) to fulfil their desire to have children. To obtain mature eggs for IVF, women typically undergo ovarian stimulation with hormones which can be very burdensome. A team of scientists of the Follicle Biology (FOBI) Research Laboratory at the Vrije Universiteit Brussel (VUB) in collaboration with the UZ Brussel fertility clinic has succeeded in developing a novel method for In Vitro Maturation (IVM) of oocytes, called CAPA-IVM.

Health - Pharmacology - 04.02.2022
VUB professor Bart Neyns takes initiative to establish Cancer Survivor Center
World Cancer Day, 4 February: Ex-cancer patients have to get used to life again Cancer patients who have survived serious treatment and are free of the disease often suffer an enormous psychological blow afterwards and find it difficult to pick up the thread of life again.

Health - Pharmacology - 04.02.2022
Four out of ten cancer survivors suffer from chronic pain
VUB research suggests pain education and lifestyle are important components of a multimodal approach to treat persistent pain Friday, February 4, 2022 — 4 February is #WorldCancerDay After cancer treatment, many patients continue to suffer from pain. About four out of ten cancer survivors have chronic pain complaints.

Health - Pharmacology - 02.02.2022
Amino acid proline key to promising new treatment strategy for myeloma patients
World Cancer Day, 4 February: Award-winning research on incurable blood cancer Researchers at the Vrije Universiteit Brussel, led by Eline Menu, have investigated how changes in metabolism contribute to cancer resistance and relapse.

Health - Pharmacology - 01.02.2022
Predictive model should avoid need for surgery in rectal cancer
Two research groups from the Vrije Universiteit Brussel have established a collaboration in which they predict the response to the standard treatment for rectal cancer based on medical images (e.g.

Health - Pharmacology - 30.01.2022
Lactic acid weakens anti-tumour defences
In cancer research, it has long been known that lactic acid, or lactate, is produced in large quantities by cancer cells and that this lactic acid disrupts our defence against tumours.

Health - Pharmacology - 06.10.2021
KU Leuven develops very potent antiviral against dengue
KU Leuven develops very potent antiviral against dengue
Researchers at the KU Leuven Rega Institute and CD3 have developed an ultrapotent inhibitor of the dengue virus, which causes the tropical disease known as dengue.

Pharmacology - Health - 23.07.2021
Important factor in transplant rejection identified
KU Leuven researchers have revealed the importance of a newly identified mechanism of kidney transplant rejection. These results could increase the chances of a successful transplantation in the future. Each year, about 500 people in our country undergo a kidney transplant. 15 to 20% of these patients experience rejection symptoms.

Health - Pharmacology - 22.07.2021
Antibiotics may help to treat melanoma
Antibiotics may help to treat melanoma
Some antibiotics appear to be effective against a form of skin cancer known as melanoma. KU Leuven researchers examined the effect of these antibiotics on patient-derived tumours in mice. Some antibiotics appear to be effective against a form of skin cancer known as melanoma. KU Leuven researchers examined the effect of these antibiotics on patient-derived tumours in mice.

Health - Pharmacology - 25.06.2021
Clinical trial with virtual patients shows great potential
Clinical trial with virtual patients shows great potential
A study involving virtual instead of real patients was as effective as traditional clinical trials in evaluating a medical device used to treat brain aneurysms, according to researchers from the University of Leeds and KU Leuven. Furthermore, the 'virtual' approach required far less time and money. A study involving virtual instead of real patients was as effective as traditional clinical trials in evaluating a medical device used to treat brain aneurysms, according to researchers from the University of Leeds and KU Leuven.

Health - Pharmacology - 19.05.2021
Cardiologist calls for increased prevention of high blood pressure
Cardiologist calls for increased prevention of high blood pressure
Wednesday, May 19, 2021 — The annual World Hypertension Day on 17 May prompted the publication of a review article on hypertension that appears today in the leading journal The Lancet. In this article, Prof Sofie Brouwers, OLV Ziekenhuis Aalst and Vrije Universiteit Brussel, and her colleagues present the current state of affairs regarding arterial hypertension.

Health - Pharmacology - 01.04.2021
VUB provides breakthrough in chronic pain management
Thursday, April 1, 2021 — An international team of experts has provided a breakthrough in the study of chronic pain in rheumatoid arthritis patients. "We discovered that hypersensitivity is often the cause for all kinds of chronic pain. Personalised treatment tailored to the patient offers the solution here,' says VUB professor Jo Nijs, who is in charge of the project.

Health - Pharmacology - 30.03.2021
VIB/VUB-team map immune cells in aggressive brain tumor
Human glioblastoma tumors are aggressive hard-to-treat brain cancers that have a high unmet need for new treatment options. A team of researchers led by Prof. Kiavash Movahedi and Prof. Jo Van Ginderachter (VIB-VUB), in collaboration with colleagues from VIB, VUB, and KU Leuven, have mapped the immune landscape in these glioblastoma tumors.

Health - Pharmacology - 08.02.2021
Scientists switch on tissue repair in inflammatory bowel disease
A method that instructs immune system cells to help repair damaged tissues in the intestine has been developed by researchers at KU Leuven and Seoul National University. This opens the way for more effective treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease. The study was carried out on humans and mice.

Health - Pharmacology - 13.01.2021
Mechanism that causes irritable bowel syndrome
KU Leuven researchers have identified the biological mechanism that explains why some people experience abdominal pain when they eat certain foods. The finding paves the way for more efficient treatment of irritable bowel syndrome and other food intolerances. Up to 20% of the world's population suffers from irritable bowel syndrome (IBS), which causes stomach pain or severe discomfort after eating.

Health - Pharmacology - 01.12.2020
Update: KU Leuven Covid-19 vaccine study published in Nature
Update: KU Leuven Covid-19 vaccine study published in Nature
Today, virologists at the KU Leuven Rega Institute published the results of their pre-clinical study into a Covid-19 vaccine candidate in  Nature . Their paper builds on a preprint that the team shared on bioRxiv earlier this year, and that  we reported on. The vaccine candidate is based on the yellow fever vaccine and thus also protects against yellow fever.
1 2 3 Next »

This site uses cookies and analysis tools to improve the usability of the site. More information. |